IP Library Assignment 045071/0265
Patent Assignment
Reel/Frame 045071/0265

Assignment of Assignor's Interest

Recorded: 2018-01-15 Pages: 44
Assignor
Assignee
WEST VIRGINIA UNIVERSITY
CHESTNUT RIDGE ROAD, MORGANTOWN, WEST VIRGINIA, 26506
Covered Properties (48)
Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
Patent: 7,682,807 →
Application: 10/469,164 →
Publication: US 2005/0059092
Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
Patent: 9,188,595 →
Application: 12/729,042 →
Publication: US 2010/0278803
Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
Application: 14/942,758 →
Publication: US 2016/0305961
Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
Application: 10/477,121 →
Publication: US 2004/0248909
Treatment of Depressive Disorders
Application: 10/594,420 →
Publication: US 2009/0041667
Treatment of Depressive Disorders
Patent: 7,977,377 →
Application: 11/802,724 →
Publication: US 2008/0003181
Treatment of Depressive Disorders
Application: 13/152,616 →
Publication: US 2011/0288022
Treatment of Depressive Disorders
Application: 13/669,353 →
Publication: US 2013/0165375
Synergistic Enhancement of Cognitive Ability
Patent: 6,821,979 →
Application: 10/172,005 →
Publication: US 2003/0171385
Synergistic enhancement of cognitive ability
Application: 10/933,275 →
Publication: US 2005/0038046
Neuroprotective effects of polyphenolic compounds
Application: 10/420,465 →
Publication: US 2004/0167217
Use of FGF-18 in the diagnosis and treatment of memory disorders
Application: 10/720,091 →
Publication: US 2004/0229292
Method for isolating subpopulations of proteins that engage in protein-protein interactions
Application: 10/519,109 →
Publication: US 2006/0275821
Artificial Low-Density Lipoprotein Carriers for Transport of Substances Across the Blood-Brain Barrier
Patent: 7,220,833 →
Application: 10/724,833 →
Publication: US 2004/0204354
Artificial Low-Density Lipoprotein Carriers for Transport of Substances Across the Blood-Brain Barrier
Patent: 7,682,627 →
Application: 11/648,808 →
Publication: US 2007/0134313
Artificial Low-Density Lipoprotein Carriers for Transport of Substances Across the Blood-Brain Barrier
Patent: 7,514,402 →
Application: 11/802,197 →
Publication: US 2007/0264351
Artificial Low-Density Lipoprotein Carriers for Transport of Substances Across the Blood-Brain Barrier
Patent: 7,576,055 →
Application: 11/802,198 →
Publication: US 2007/0292413
Artificial Low-Density Lipoprotein Carriers for Transport of Substances Across the Blood-Brain Barrier
Patent: 7,803,400 →
Application: 11/802,727 →
Publication: US 2008/0160094
Carbonic anhydrase activator for enhancing learning and memory
Application: 10/476,459 →
Publication: US 2004/0235889
Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease
Application: 11/660,868 →
Publication: US 2009/0029355
Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease
Application: 13/768,447 →
Publication: US 2013/0273545
Semiconductor fabrication device heater and heating device equipped with the same
Application: 11/256,524 →
Publication: US 2006/0102613
Alzheimer's Disease-Specific Alterations of the ERK1/ERK2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
Application: 12/083,056 →
Publication: US 2009/0029873
Alzheimer's disease-specific alterations of the ERK1/ERK2 Phosphorylation ratio-Alzheimer's disease-specific molecular biomarkers (ADSMB)
Application: 12/078,857 →
Publication: US 2008/0221042
Alzheimer's Disease-Specific Alterations of the ERK1/ERK2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
Patent: 9,797,913 →
Application: 13/774,049 →
Publication: US 2014/0031245
Alzheimer's Disease-Specific Alterations of the ERK1/ERK2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
Application: 15/719,714 →
Publication: US 2018/0024146
Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury
Application: 12/068,732 →
Publication: US 2009/0036514
Therapeutic Effects of Bryostatins, Bryologs, and Other Related Substances on Ischemia/Stroke-Induced Memory Impairment and Brain Injury
Application: 13/553,565 →
Publication: US 2013/0165453
Stimulus-Elicited Genomic Profile Markers of Alzheimer's Disease
Patent: 8,822,166 →
Application: 12/510,707 →
Publication: US 2010/0021913
Abnormal Alterations of Pkc Isozymes Processing in Alzheimer's Disease Peripheral Cells
Application: 12/895,957 →
Publication: US 2011/0212474
Fibroblast Growth Patterns for Diagnosis of Alzheimer's Disease
Patent: 8,658,134 →
Application: 12/896,862 →
Publication: US 2011/0136144
Fibroblast Growth Patterns for Diagnosis of Alzheimer's Disease
Application: 14/176,233 →
Publication: US 2014/0329264
Alzheimer's Disease-Specific Alterations of Protein Kinase C Epsilon (Pkc-Epsilon) Protein Levels
Application: 13/580,431 →
Publication: US 2014/0038186
Pkc Activators and Anticoagulant in Regimen for Treating Stroke
Patent: 9,107,890 →
Application: 13/178,843 →
Publication: US 2012/0034205
Pkc Activators and Anticoagulant in Regimen for Treating Stroke
Patent: 9,889,183 →
Application: 14/818,576 →
Publication: US 2016/0184414
Peripheral Diagnostic Methods for Screening Alzheimer's Disease Using Beta Amyloid and Intercellular Communication
Application: 14/116,138 →
Publication: US 2014/0248648
Stimulus-Elicited Genomic Profile Markers of a Neurodegenerative Condition
Application: 14/346,822 →
Publication: US 2014/0235496
Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases
Patent: 9,962,357 →
Application: 15/028,487 →
Publication: US 2016/0256427
Convergence of Aggregation Rate with Validated Peripheral Diagnostic for Alzheimer's Disease
Application: 15/107,152 →
Publication: US 2017/0023552
Methods for Classifying Populations Including Alzheimer's Disease Populations
Application: 15/555,566 →
Treatment of Neurodegenerative Conditions Using Pkc Activators After Determining the Presence of the APOE4 Allele
Application: 15/572,946 →
Publication: US 2018/0217163
Peripheral Diagnostic Methods for Screening Alzheimer's Disease Using Beta Amyloid and Intercellular Communication
Application: 61/485,256 →
Fluorinated Pkc Epsilon Activators for Treatment of Neurodegenerative Diseases
Application: 61/925,449 →
Convergence of Aggregation Rate with Validated Peripheral Biomarkers for Alzheimer's Disease
Application: 61/923,373 →
Methods Utilizing Isometric Transformations
Application: 62/129,715 →
Data Class Separation Through Isometric Transformations
Application: 62/198,838 →
APOE4 AND alphabeta OLIGOMERS REDUCE BDNF EXPRESSION VIA HDAC NUCLEAR TRANSLOCATION
Application: 62/159,691 →
Diagnosing Mild Cognitive Impairment (Mci), Predicting Alzheimer's Disease (Ad) Dementia Onset, and Screening and Monitoring Agents for Treating Mci or Preventing Dementia Onset
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 25, 2003
From: OOI, KOZO; YAMAGUCHI, MASAO; TAMAI, MIKITAKA
To: SANYO ELECTRIC CO., LTD.
Reel/Frame 014744/0287 →
To Correct Serial Number on Reel/Frame 015060/0557 Mar 10, 2004
From: ZHAO, WEI-QIN; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEURSOCIENCES INSTITUTE
Reel/Frame 015869/0897 →
Assignment of Assignor's Interest Mar 10, 2004
From: ALKON, DANIEL L.; SUN, MIAO-KUN
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 015060/0554 →
Assignment of Assignor's Interest Mar 10, 2004
From: CAVALLARO, SEBASTIANO; D'AGATA, VELIA; DUFOUR, FRANCK; PACHIAPPAN, MANICKAM
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 015060/0526 →
Assignment of Assignor's Interest Mar 10, 2004
From: NELSON, THOMAS; QUATARONE, ALESSANDRO; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 015060/0519 →
Assignment of Assignor's Interest Mar 10, 2004
From: SUN, MIAO-KUN; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 015060/0510 →
Assignment of Assignor's Interest Apr 6, 2004
From: SUN, MIAO-KUN; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 015182/0288 →
Assignment of Assignor's Interest Apr 6, 2004
From: ALKON, DANIEL L.; SCAPAGNINI, GIOVANNI; COLOMBRITA, CLAUDIA
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 015182/0541 →
Assignment of Assignor's Interest Jul 28, 2005
From: NELSON, THOMAS J.; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 016579/0135 →
Assignment of Assignor's Interest Jan 3, 2007
From: NELSON, THOMAS; QUATTRONE, ALESSANDRO; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 018762/0484 →
Assignment of Assignor's Interest Jan 3, 2007
From: NELSON, THOMAS; QUATTRONE, ALESSANDRO; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 018706/0583 →
Assignment of Assignor's Interest Jul 2, 2008
From: ALKON, DANIEL L.; ZHAO,WEI-QIN
To: BLANCHETTE ROCKEFELLER NEUROSCIENCE INSTITUTE
Reel/Frame 021190/0845 →
Assignment of Assignor's Interest Oct 3, 2008
From: ZHAO, WEI-QIN; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 021634/0911 →
Assignment of Assignor's Interest Mar 18, 2009
From: SUN, MIAO-KUN; ALKON, DANIEL L.; NELSON, THOMAS
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 022418/0856 →
Assignment of Assignor's Interest Sep 29, 2009
From: NELSON, THOMAS J; ALKON, DANIEL L; QUATTRONE, ALESSANDRO
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 023298/0865 →
Assignment of Assignor's Interest Aug 25, 2011
From: SUN, MIAO-KUN; ALKON, DANIEL L.
To: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Reel/Frame 026804/0993 →
Assignment of Assignor's Interest Feb 15, 2021
From: BLANCHETTE ROCKEFELLER NEUROSCIENSES INSTITUTE, INC.
To: WEST VIRGINIA UNIVERSITY
Reel/Frame 055304/0423 →